Search
for

    Sort by

    Research 931–960 of 1000+

    1. Finasteride Springer eBooks · 2011 · 2 citations
    2. 1726: Risk Decrease of Intra-Operative Bleeding During TURP with the Uptake of Finasteride: Evaluation of VEGF and CD34 The Journal of Urology · 2007
    3. Every TURP Is not Just BPH American Journal of Clinical Pathology · 2022
    4. Clinical applications of antiandrogens Journal of Steroid Biochemistry · 1988 · 29 citations
    5. Post-Finasteride Syndrome: An Underestimated Phenomenon Urology and andrology · 2017
    6. The prolactin receptor as a therapeutic target in human diseases: browsing new potential indications Expert Opinion on Therapeutic Targets · 2015 · 38 citations
    7. Dutasteride Drugs · 2008 · 45 citations
    8. Health Issues Unique to the Aging Man Geriatric nursing · 2000 · 3 citations
    9. The clinical applications of five-alpha reductase inhibitors. Canadian Journal of Urology · 2021 · 2 citations
    10. Hormone Blocking Anticancer Drugs 2015
    11. Uromedic® Pumpkin Seed Derived Δ7-Sterols, Extract and Oil Inhibit 5α-Reductases and Bind to Androgen Receptor <em>in Vitro</em> Pharmacology & pharmacy · 2018 · 12 citations
    12. Men??s Health Drugs in R & D · 1999
    13. Pharmacological Profile of 9,11-Dehydrocortexolone 17α-Butyrate (CB-03-04), a New Androgen Antagonist with Antigonadotropic Activity Arzneimittelforschung · 2011 · 1 citations
    14. Medicine Update IJCP · 2024
    15. THE ROLE Of 5αR AND α1AR INHIBITORS IN MANAGEMENT OF BPH 2019
    16. Influence of Clinical and Sociodemographic Factors on the Management, Costs, and Outcomes of Acute Urinary Retention in the Acute Care Setting Urology Practice · 2022
    17. Estrogen and androgen signaling in the pathogenesis of BPH Nature reviews. Urology · 2011 · 149 citations
    18. Anti-nociceptive and anti-inflammatory properties of 5alpha-reductase inhibitor finasteride in experimental animals European Journal of Drug Metabolism and Pharmacokinetics · 2008 · 11 citations
    19. Pharmacokinetic Interaction between Finasteride and Terazosin, but not Finasteride and Doxazosin The Journal of Clinical Pharmacology · 1998 · 6 citations
    20. The Benefits of Dual Inhibition of 5α Reductase European Urology Supplements · 2006 · 4 citations
    21. Risk of age-related macular degeneration in men receiving 5α-reductase inhibitors: a population-based cohort study Age and Ageing · 2024
    22. Validated HPTLC method for the simultaneous determination of alfuzosin, terazosin, prazosin, doxazosin and finasteride in pharmaceutical formulations Analytical Chemistry Research · 2014 · 26 citations
    23. The Steroidogenesis Inhibitor Finasteride Reduces the Response to Both Stressful and Rewarding Stimuli Biomolecules · 2019 · 20 citations
    24. Spectrophotometric method for the estimation of finasteride in tablets Indian Journal of Pharmaceutical Sciences · 2002 · 4 citations
    25. A retrospective study of clinical outcomes of α-blocker or finasteride monotherapy followed by combination therapy: determination of the period of combination therapy of α-blocker and finasteride International Journal of Clinical Practice · 2013 · 3 citations
    26. Is Dutasteride a Therapeutic Alternative for Amyotrophic Lateral Sclerosis? Biomedicines · 2022 · 1 citations
    27. Tamsulosin versus finasteride: effect on bother and urinary flow European Urology Supplements · 2002 · 1 citations
    28. Depression risk of 5-alpha reductase inhibitors: impact of active-comparator versus non-drug user control groups on risk measurement Postgraduate Medicine · 2026
    29. An improved synthesis of finasteride from 4-androsten-3,17-dione Asian Journal of Research in Chemistry · 2010
    30. The 5α-reductase inhibitor finasteride reduces opioid self-administration bioRxiv (Cold Spring Harbor Laboratory) · 2020